We confirmed the association between KRAS and PIK3CA mutations in CRC, which was comparable with previous studies [14], [20], [25], [32], and only exon9 (not included exon20) shared a strong association with KRAS mutation [14]. This evidence concerns the gene KRAS and colorectal carcinoma.